• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
The Cutting Edge

PET Imaging Technology to Improve Cancer Treatment

  PET Imaging Technology to Improve Cancer Treatment
  A representative [18F]CFA PET image in humans. Arrows indicate liver, lymph nodes, spleen and bone marrow, which express high levels of dCK.
Image: UCLA Department of Molecular and Medical Pharmacology

A discovery by UCLA scientists could lead to a new method of identifying cancer patients who have high levels of an enzyme and are more likely to respond to cancer treatments. Decades of significant advances and improvements in positron emission tomography (PET) have led to the detection of an enzyme in humans that plays a significant role in DNA formation. The enzyme, called deoxycytidine kinase (dCK), was previously found to be highly expressed in acute leukemia cells and in activated lymphocytes and controls a critical step in the nucleoside salvage pathway, an important therapeutic and PET-imaging target in cancer.

In a seven-year study, a team of UCLA researchers led by Caius Radu, MD, professor of molecular and medical pharmacology, developed a highly sophisticated PET probe called [18F]CFA that is capable of detecting dCK activity in humans for the first time. “The quality of the images is much better,” Dr. Radu says. “We are able to clearly see tissues, including tumor tissues, with high dCK activity that we haven’t seen before in humans using any of the other probes previously developed for this enzyme.”

PET is a noninvasive imaging technology that uses a radioactive substance, called PET probe, to look for disease in the body, and it also shows how organs and tissues are functioning. Until recently, PET technology was only able to clearly detect dCK in mice due to metabolic instability of the previous probes and cross-reactivity with a dCK-related enzyme in humans. The dCK enzyme plays an integral role in allowing drugs such as clofarabine, cytarabine and fludarabine to treat certain types of leukemia, and others like gemcitabine to treat breast, ovarian, non-small-cell lung and pancreatic cancers.

“This enzyme is essential for the therapeutic activity of an entire class of anticancer drugs and even for some antiviral drugs,” Dr. Radu says. “It can take an inactive drug and activate it. If you trick a cancer cell or virus to activate the drug, it would be toxic for the cancer cell or viral genome.”

Because activated immune cells increase their expression of the dCK enzyme, [18F]CFA could also be used to monitor the effectiveness of immunotherapeutic interventions, Dr. Radu says. The researchers hope to begin clinical trials with the [18F]CFA soon.

“[18F]CFA as a Clinically Translatable Probe for PET Imaging of Deoxycytidine Kinase Activity,” Proceedings of the National Academy of Sciences of the United States of America, April 12, 2016


Previous
A Key to Unlock Effective Personalized Medicine
Next
Empathy for the Empathically Challenged


YOU ARE VIEWING

Summer 2016

Summer 2016
E-Brochure
Printable PDF
IN THIS ISSUE
  • For the Public Good
  • Genetic Evolution of Zika Virus Unraveled
  • Exome Sequencing Improves Ability to Diagnose Neurogenetic Disorders
  • Impaired Stress Hormone before Pregnancy Predicts Lower-birthweight Babies
  • Surgery Better than Widely Used Medications to Treat Osteoporosis
  • Steps toward Potential Treatments for Central Nervous System Injury
  • Majority of California Adults Have Prediabetes or Diabetes
  • Promising New Approach to Treat Duchenne Muscular Dystrophy
  • A Key to Unlock Effective Personalized Medicine
  • PET Imaging Technology to Improve Cancer Treatment
  • Empathy for the Empathically Challenged
  • Glial Scarring Enhances Nerve-cell Regrowth
  • Helping U Help the Community: The Winners Are ...
  • Raising the Bar
  • Memories Are Made of This
  • Balms of Gilead
  • Dramatic Turn
  • Healthy Lifestyle, Healthy Memory
  • Awards & Honors
  • Reflection: Building a Legacy
  • In Her Own Words: Marie Crandall, MD ’96, MPH
  • Standing on the Shoulders of a Giant
  • UCLA Joins Parker Institute Collaboration to Advance Cancer Immunotherapy Research
  • UCLA Honors Longtime Benefactors with The UCLA Medal, Celebrates Inaugural Chair Holders
  • Gift from Arline and Henry Gluck to Pioneer Innovative Stroke Treatment
  • Taking on the Grand Challenge of Depression
  • Samuel Steinberg: Celebrating a Life of Compassion
  • Taste for a Cure: A Winning Event
  • UCLA Neurosurgery Celebrates Tom and Nadia Davies' Philanthropy and the Inaugural Davies Chair Holder
  • UCLA Helps Young People Develop Sound Bodies and Minds
  • New UCLA Operation Mend Program Treats the Hidden Wounds of War
  • An Afternoon of Good Food and Friends at Vibiana Raises Money for Scholarships
  • Fourth Annual Tour de Pier Fundraiser Tops $1 Million for Cancer Research and Services
  • Generous Philanthropy Launches UCLA Center to Support Emotionally Healthy Children
  • Gifts
  • Faculty Giving Back
  • In Memoriam
  • Family Support
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth